pharmaceutical investing Keryx Biopharmaceuticals Announces Changes to Management and Preliminary First Quarter 2018 Revenue
pharmaceutical investing Keryx Biopharmaceuticals Announces Publication of Data from the Phase 3 Trial of Auryxia
EnerCom Announces SM Energy as a Keynote Speaker at the 31st EnerCom Denver - The Energy Investment Conference, on August 19, 2026, in Denver, Colorado
